NASDAQ
Canntab Therapeutics Limited (CTABF) has a eps (diluted) of $-0.10 as of Tuesday, May 31, 2022. Diluted EPS accounts for all potential shares from stock options and convertible securities, providing a more conservative earnings-per-share measure.
No price data available for this timeframe.